nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—PLA2G2A—atherosclerosis	0.357	0.452	CbGaD
Suramin—SIRT1—atherosclerosis	0.304	0.385	CbGaD
Suramin—F2—atherosclerosis	0.129	0.163	CbGaD
Suramin—F2—vein—atherosclerosis	0.00596	0.0859	CbGeAlD
Suramin—F2—leg—atherosclerosis	0.00444	0.0639	CbGeAlD
Suramin—F2—hindlimb—atherosclerosis	0.00396	0.0571	CbGeAlD
Suramin—SIRT1—endothelium—atherosclerosis	0.00388	0.0559	CbGeAlD
Suramin—SIRT1—blood vessel—atherosclerosis	0.00358	0.0516	CbGeAlD
Suramin—F2—appendage—atherosclerosis	0.0034	0.049	CbGeAlD
Suramin—FSHR—connective tissue—atherosclerosis	0.00337	0.0486	CbGeAlD
Suramin—P2RY2—cardiovascular system—atherosclerosis	0.00312	0.045	CbGeAlD
Suramin—FSHR—adipose tissue—atherosclerosis	0.00259	0.0373	CbGeAlD
Suramin—F2—artery—atherosclerosis	0.00243	0.035	CbGeAlD
Suramin—F2—endothelium—atherosclerosis	0.00205	0.0296	CbGeAlD
Suramin—SIRT5—cardiovascular system—atherosclerosis	0.00193	0.0278	CbGeAlD
Suramin—F2—blood vessel—atherosclerosis	0.00189	0.0273	CbGeAlD
Suramin—SIRT1—connective tissue—atherosclerosis	0.00184	0.0264	CbGeAlD
Suramin—ARSA—connective tissue—atherosclerosis	0.00181	0.0261	CbGeAlD
Suramin—SIRT5—adipose tissue—atherosclerosis	0.0017	0.0245	CbGeAlD
Suramin—P2RX4—adipose tissue—atherosclerosis	0.00161	0.0232	CbGeAlD
Suramin—SIRT1—cardiovascular system—atherosclerosis	0.0016	0.023	CbGeAlD
Suramin—RYR1—cardiovascular system—atherosclerosis	0.00148	0.0213	CbGeAlD
Suramin—SIRT1—adipose tissue—atherosclerosis	0.00141	0.0203	CbGeAlD
Suramin—ARSA—adipose tissue—atherosclerosis	0.00139	0.02	CbGeAlD
Suramin—PLA2G2A—connective tissue—atherosclerosis	0.00129	0.0185	CbGeAlD
Suramin—SIRT5—liver—atherosclerosis	0.00119	0.0172	CbGeAlD
Suramin—P2RX4—liver—atherosclerosis	0.00113	0.0162	CbGeAlD
Suramin—PLA2G2A—cardiovascular system—atherosclerosis	0.00112	0.0161	CbGeAlD
Suramin—SIRT1—liver—atherosclerosis	0.000988	0.0142	CbGeAlD
Suramin—PLA2G2A—adipose tissue—atherosclerosis	0.000986	0.0142	CbGeAlD
Suramin—ARSA—liver—atherosclerosis	0.000975	0.0141	CbGeAlD
Suramin—F2—connective tissue—atherosclerosis	0.00097	0.014	CbGeAlD
Suramin—RYR1—liver—atherosclerosis	0.000912	0.0131	CbGeAlD
Suramin—PLA2G4A—connective tissue—atherosclerosis	0.000893	0.0129	CbGeAlD
Suramin—F2—cardiovascular system—atherosclerosis	0.000844	0.0122	CbGeAlD
Suramin—PLA2G4A—cardiovascular system—atherosclerosis	0.000777	0.0112	CbGeAlD
Suramin—PLA2G2A—liver—atherosclerosis	0.000691	0.00996	CbGeAlD
Suramin—PLA2G4A—adipose tissue—atherosclerosis	0.000686	0.00988	CbGeAlD
Suramin—F2—liver—atherosclerosis	0.000522	0.00752	CbGeAlD
Suramin—PLA2G4A—Signaling Pathways—CCL4—atherosclerosis	1.52e-05	0.000108	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—NOS2—atherosclerosis	1.51e-05	0.000108	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.51e-05	0.000107	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—MTHFR—atherosclerosis	1.5e-05	0.000107	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PLA2G1B—atherosclerosis	1.5e-05	0.000106	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—KNG1—atherosclerosis	1.49e-05	0.000106	CbGpPWpGaD
Suramin—ARSA—Metabolism—PTGS2—atherosclerosis	1.49e-05	0.000106	CbGpPWpGaD
Suramin—F2—Signaling Pathways—UTS2—atherosclerosis	1.48e-05	0.000105	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.48e-05	0.000105	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—AGTR1—atherosclerosis	1.48e-05	0.000105	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PPARA—atherosclerosis	1.47e-05	0.000105	CbGpPWpGaD
Suramin—F2—Hemostasis—IGF1—atherosclerosis	1.47e-05	0.000104	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—PIK3CG—atherosclerosis	1.47e-05	0.000104	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.47e-05	0.000104	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.46e-05	0.000104	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ALOX5—atherosclerosis	1.44e-05	0.000103	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—MMP1—atherosclerosis	1.44e-05	0.000103	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—AGT—atherosclerosis	1.43e-05	0.000101	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—AGT—atherosclerosis	1.43e-05	0.000101	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—APOA2—atherosclerosis	1.42e-05	0.000101	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CX3CR1—atherosclerosis	1.42e-05	0.000101	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CASR—atherosclerosis	1.42e-05	0.000101	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CXCL8—atherosclerosis	1.4e-05	9.95e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—APOE—atherosclerosis	1.4e-05	9.93e-05	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—LEP—atherosclerosis	1.4e-05	9.93e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—SERPINE1—atherosclerosis	1.39e-05	9.91e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CX3CL1—atherosclerosis	1.39e-05	9.9e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—ALB—atherosclerosis	1.39e-05	9.89e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CAV1—atherosclerosis	1.39e-05	9.84e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—APOA1—atherosclerosis	1.38e-05	9.82e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—EDN1—atherosclerosis	1.38e-05	9.81e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CCL5—atherosclerosis	1.37e-05	9.73e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—KNG1—atherosclerosis	1.36e-05	9.67e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—UTS2—atherosclerosis	1.36e-05	9.63e-05	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—AKT1—atherosclerosis	1.35e-05	9.61e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CXCL8—atherosclerosis	1.35e-05	9.61e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—AGTR1—atherosclerosis	1.35e-05	9.61e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IGF1—atherosclerosis	1.34e-05	9.54e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.33e-05	9.49e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—IL6—atherosclerosis	1.33e-05	9.46e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—NOS3—atherosclerosis	1.33e-05	9.46e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CNR2—atherosclerosis	1.32e-05	9.39e-05	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CXCL8—atherosclerosis	1.32e-05	9.38e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—MMP3—atherosclerosis	1.32e-05	9.36e-05	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	1.31e-05	9.34e-05	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—AKT1—atherosclerosis	1.31e-05	9.28e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—PRKCG—atherosclerosis	1.3e-05	9.25e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CX3CR1—atherosclerosis	1.3e-05	9.23e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CASR—atherosclerosis	1.3e-05	9.23e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—NAMPT—atherosclerosis	1.3e-05	9.21e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.29e-05	9.15e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—LIPC—atherosclerosis	1.29e-05	9.15e-05	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—IL6—atherosclerosis	1.29e-05	9.14e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—APOC3—atherosclerosis	1.28e-05	9.09e-05	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—MAPK3—atherosclerosis	1.28e-05	9.08e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—SERPINE1—atherosclerosis	1.27e-05	9.06e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CX3CL1—atherosclerosis	1.27e-05	9.06e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—ALB—atherosclerosis	1.27e-05	9.04e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—LDLR—atherosclerosis	1.27e-05	9.04e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MMP9—atherosclerosis	1.27e-05	9e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PIK3CG—atherosclerosis	1.26e-05	8.97e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—EDN1—atherosclerosis	1.25e-05	8.91e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—NFKB1—atherosclerosis	1.25e-05	8.91e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CCL5—atherosclerosis	1.24e-05	8.84e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CETP—atherosclerosis	1.24e-05	8.83e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MAPK8—atherosclerosis	1.23e-05	8.75e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—AKT1—atherosclerosis	1.23e-05	8.73e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MMP9—atherosclerosis	1.22e-05	8.69e-05	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.22e-05	8.67e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PPARG—atherosclerosis	1.22e-05	8.65e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—NOS3—atherosclerosis	1.22e-05	8.65e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—NFKB1—atherosclerosis	1.21e-05	8.6e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CNR2—atherosclerosis	1.21e-05	8.58e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—MMP3—atherosclerosis	1.21e-05	8.56e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—INS—atherosclerosis	1.19e-05	8.49e-05	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—INS—atherosclerosis	1.19e-05	8.48e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MAPK8—atherosclerosis	1.19e-05	8.45e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—SCARB1—atherosclerosis	1.19e-05	8.45e-05	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.19e-05	8.43e-05	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—AKT1—atherosclerosis	1.19e-05	8.43e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PRKCG—atherosclerosis	1.18e-05	8.4e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—VWF—atherosclerosis	1.18e-05	8.37e-05	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—CCL2—atherosclerosis	1.17e-05	8.35e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—APOC3—atherosclerosis	1.17e-05	8.31e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—LDLR—atherosclerosis	1.16e-05	8.26e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.16e-05	8.23e-05	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—IGF1—atherosclerosis	1.15e-05	8.21e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—EDN1—atherosclerosis	1.15e-05	8.15e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—AGT—atherosclerosis	1.15e-05	8.14e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CCL5—atherosclerosis	1.14e-05	8.08e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—VEGFA—atherosclerosis	1.14e-05	8.08e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCL3—atherosclerosis	1.14e-05	8.07e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—STAT3—atherosclerosis	1.13e-05	8e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—HMGCR—atherosclerosis	1.12e-05	7.98e-05	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—MMP2—atherosclerosis	1.12e-05	7.94e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—VEGFA—atherosclerosis	1.1e-05	7.81e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ALB—atherosclerosis	1.09e-05	7.78e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—STAT3—atherosclerosis	1.09e-05	7.73e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NCF1—atherosclerosis	1.09e-05	7.73e-05	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.09e-05	7.71e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PRKCG—atherosclerosis	1.08e-05	7.69e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—VWF—atherosclerosis	1.08e-05	7.65e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MAPK3—atherosclerosis	1.08e-05	7.65e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—APOC3—atherosclerosis	1.07e-05	7.6e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—LDLR—atherosclerosis	1.06e-05	7.56e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—NOS3—atherosclerosis	1.05e-05	7.44e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TGFB1—atherosclerosis	1.04e-05	7.42e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—AGT—atherosclerosis	1.04e-05	7.39e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MAPK3—atherosclerosis	1.04e-05	7.38e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCL3—atherosclerosis	1.04e-05	7.38e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—EDNRA—atherosclerosis	1.03e-05	7.3e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCR2—atherosclerosis	1.03e-05	7.3e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CYBA—atherosclerosis	1.02e-05	7.27e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.01e-05	7.2e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—PIK3CG—atherosclerosis	1.01e-05	7.2e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TGFB1—atherosclerosis	1.01e-05	7.16e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ABCA1—atherosclerosis	1e-05	7.12e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PLAT—atherosclerosis	1e-05	7.11e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PARP1—atherosclerosis	1e-05	7.11e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GHRL—atherosclerosis	1e-05	7.11e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NCF1—atherosclerosis	9.95e-06	7.07e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—VEGFA—atherosclerosis	9.59e-06	6.81e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PTGS2—atherosclerosis	9.58e-06	6.81e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—AGT—atherosclerosis	9.51e-06	6.76e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCR2—atherosclerosis	9.39e-06	6.68e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—EDNRA—atherosclerosis	9.39e-06	6.68e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CYBA—atherosclerosis	9.35e-06	6.65e-05	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—CXCL8—atherosclerosis	9.29e-06	6.6e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PIK3CG—atherosclerosis	9.2e-06	6.54e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PARP1—atherosclerosis	9.15e-06	6.51e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GHRL—atherosclerosis	9.15e-06	6.51e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PLAT—atherosclerosis	9.15e-06	6.51e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—MAPK3—atherosclerosis	9.07e-06	6.44e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—TGFB1—atherosclerosis	8.8e-06	6.25e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—F2—atherosclerosis	8.79e-06	6.25e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—KNG1—atherosclerosis	8.79e-06	6.24e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—VEGFA—atherosclerosis	8.77e-06	6.23e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AGTR1—atherosclerosis	8.73e-06	6.21e-05	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—AKT1—atherosclerosis	8.62e-06	6.12e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—HMOX1—atherosclerosis	8.59e-06	6.11e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CCL2—atherosclerosis	8.57e-06	6.09e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PLG—atherosclerosis	8.51e-06	6.05e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PIK3CG—atherosclerosis	8.41e-06	5.98e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—MAPK3—atherosclerosis	8.29e-06	5.89e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—APOB—atherosclerosis	8.23e-06	5.85e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SOCS3—atherosclerosis	8.06e-06	5.73e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TGFB1—atherosclerosis	8.05e-06	5.72e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—KNG1—atherosclerosis	8.04e-06	5.71e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GSTM1—atherosclerosis	8.01e-06	5.69e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AGTR1—atherosclerosis	7.99e-06	5.68e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IL6—atherosclerosis	7.87e-06	5.59e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—LPL—atherosclerosis	7.86e-06	5.58e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CCL2—atherosclerosis	7.84e-06	5.57e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MMP3—atherosclerosis	7.78e-06	5.53e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PLG—atherosclerosis	7.78e-06	5.53e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IGF2—atherosclerosis	7.75e-06	5.51e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GPX1—atherosclerosis	7.67e-06	5.45e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IL6—atherosclerosis	7.6e-06	5.4e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—APOB—atherosclerosis	7.52e-06	5.35e-05	CbGpPWpGaD
Suramin—ARSA—Metabolism—AKT1—atherosclerosis	7.47e-06	5.31e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CD36—atherosclerosis	7.47e-06	5.31e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CXCL8—atherosclerosis	7.46e-06	5.3e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—EDN1—atherosclerosis	7.4e-06	5.26e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SOCS3—atherosclerosis	7.37e-06	5.24e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCL5—atherosclerosis	7.35e-06	5.22e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—AKT1—atherosclerosis	7.26e-06	5.16e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—LPL—atherosclerosis	7.18e-06	5.11e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MMP3—atherosclerosis	7.12e-06	5.06e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IGF2—atherosclerosis	7.09e-06	5.04e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—MTHFR—atherosclerosis	7.07e-06	5.03e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—AKT1—atherosclerosis	7.01e-06	4.98e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PRKCG—atherosclerosis	6.98e-06	4.96e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PPARA—atherosclerosis	6.94e-06	4.93e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—APOB—atherosclerosis	6.88e-06	4.89e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SPP1—atherosclerosis	6.8e-06	4.84e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CXCL8—atherosclerosis	6.77e-06	4.81e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—EDN1—atherosclerosis	6.77e-06	4.81e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—AGT—atherosclerosis	6.72e-06	4.78e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCL5—atherosclerosis	6.72e-06	4.78e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—APOE—atherosclerosis	6.59e-06	4.68e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—LPL—atherosclerosis	6.57e-06	4.67e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CAV1—atherosclerosis	6.53e-06	4.64e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—APOA1—atherosclerosis	6.51e-06	4.63e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PRKCG—atherosclerosis	6.39e-06	4.54e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PDGFB—atherosclerosis	6.3e-06	4.47e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SPP1—atherosclerosis	6.22e-06	4.42e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CXCL8—atherosclerosis	6.2e-06	4.4e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AGT—atherosclerosis	6.15e-06	4.37e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—AKT1—atherosclerosis	6.12e-06	4.35e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—LEP—atherosclerosis	6.02e-06	4.28e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—APOE—atherosclerosis	6.02e-06	4.28e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CAV1—atherosclerosis	5.97e-06	4.24e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—APOA1—atherosclerosis	5.95e-06	4.23e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PIK3CG—atherosclerosis	5.94e-06	4.22e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PDGFB—atherosclerosis	5.76e-06	4.09e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ESR1—atherosclerosis	5.75e-06	4.09e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PPARG—atherosclerosis	5.74e-06	4.08e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—INS—atherosclerosis	5.63e-06	4e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AGT—atherosclerosis	5.62e-06	3.99e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—AKT1—atherosclerosis	5.59e-06	3.98e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—APOE—atherosclerosis	5.51e-06	3.91e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—LEP—atherosclerosis	5.51e-06	3.91e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CAV1—atherosclerosis	5.46e-06	3.88e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—APOA1—atherosclerosis	5.44e-06	3.87e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PIK3CG—atherosclerosis	5.43e-06	3.86e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ESR1—atherosclerosis	5.26e-06	3.74e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—MAPK3—atherosclerosis	5.2e-06	3.7e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—F2—atherosclerosis	5.19e-06	3.69e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ALB—atherosclerosis	5.16e-06	3.67e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—INS—atherosclerosis	5.14e-06	3.66e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCL2—atherosclerosis	5.06e-06	3.6e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IGF1—atherosclerosis	4.98e-06	3.54e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PIK3CG—atherosclerosis	4.97e-06	3.53e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—NOS3—atherosclerosis	4.93e-06	3.51e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—AKT1—atherosclerosis	4.81e-06	3.42e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—MAPK3—atherosclerosis	4.76e-06	3.38e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SERPINE1—atherosclerosis	4.73e-06	3.36e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—INS—atherosclerosis	4.7e-06	3.34e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCL2—atherosclerosis	4.63e-06	3.29e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IGF1—atherosclerosis	4.55e-06	3.23e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PTGS2—atherosclerosis	4.51e-06	3.21e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NOS3—atherosclerosis	4.51e-06	3.21e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SERPINE1—atherosclerosis	4.32e-06	3.07e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NOS3—atherosclerosis	4.13e-06	2.93e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CXCL8—atherosclerosis	4e-06	2.84e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—AKT1—atherosclerosis	3.87e-06	2.75e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL6—atherosclerosis	3.81e-06	2.7e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CXCL8—atherosclerosis	3.66e-06	2.6e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MMP9—atherosclerosis	3.62e-06	2.57e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NFKB1—atherosclerosis	3.58e-06	2.54e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MAPK8—atherosclerosis	3.52e-06	2.5e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—AKT1—atherosclerosis	3.51e-06	2.49e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL6—atherosclerosis	3.48e-06	2.47e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MMP9—atherosclerosis	3.31e-06	2.35e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NFKB1—atherosclerosis	3.28e-06	2.33e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—VEGFA—atherosclerosis	3.25e-06	2.31e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MAPK8—atherosclerosis	3.22e-06	2.29e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—STAT3—atherosclerosis	3.22e-06	2.29e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—AKT1—atherosclerosis	3.21e-06	2.28e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MAPK3—atherosclerosis	3.07e-06	2.18e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TGFB1—atherosclerosis	2.98e-06	2.12e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—VEGFA—atherosclerosis	2.97e-06	2.11e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—STAT3—atherosclerosis	2.94e-06	2.09e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MAPK3—atherosclerosis	2.81e-06	2e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TGFB1—atherosclerosis	2.73e-06	1.94e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—AKT1—atherosclerosis	2.27e-06	1.61e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL6—atherosclerosis	2.25e-06	1.6e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AKT1—atherosclerosis	2.07e-06	1.47e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL6—atherosclerosis	2.06e-06	1.46e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AKT1—atherosclerosis	1.9e-06	1.35e-05	CbGpPWpGaD
